智通财经APP获悉，德适-B(02526)尾盘涨超9%，截至发稿，涨%9.01，报326.8港元，成交额4048.94万港元。
消息面上，德适近日披露2025年业绩。全年总收入1.64亿元，同比激增133.7%；毛利1.18亿元、同比大增157%。财报显示，公司技术许可业务收入从上年同期的1954万元飙升至8434万元，同比暴增331.7%，首次占据总营收的半壁江山，跃升为第一大收入来源。技术许可业务的毛利率接近87.3%，几乎触及了模型服务行业的理论天花板。
智通财经APP在《德适-B（02526）：技术许可暴增331.7%引爆“造血”元年，以基座模型构筑全球AI医疗基础设施》中指出，德适2025年的年报，无疑是其迄今最有力的一次自我证明。技术许可收入暴增332%，验证了大模型商业闭环的可行性；30.6%的市占率，守住了政策性刚需赛道的绝对领先地位；而iMedImage®基座模型获得腾讯等头部机构的背书，则深刻印证了其作为全球AI医疗基础设施服务商的战略价值。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.